Atara Biotherapeutics Inc logo

Atara Biotherapeutics Inc

$ 4.94 -0.4 (-7.49%) 04:00 PM EST
P/E:
At Loss
P/B:
1.81
Market Cap:
$ 466.15M
Enterprise V:
$ 236.58M
Volume:
2.13M
Avg Vol (2M):
3.09M
Also Trade In:
Volume:
2.13M
Market Cap $:
466.15M
PE Ratio:
At Loss
Avg Vol (2-Month):
3.09M
Enterprise Value $:
236.58M
PB Ratio:
1.81
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials
Market Cap $ M 466.15
Enterprise Value $ M 236.58
P/E(ttm) --
PE Ratio without NRI --
Forward PE Ratio --
Price/Book 1.81
Price/Sales 6.92
Price/Free Cash Flow --
Price/Owner Earnings --
Payout Ratio % --
Revenue (TTM) $ M 71.00
EPS (TTM) $ -2.55
Beneish M-Score 5.96
10-y EBITDA Growth Rate % --
5-y EBITDA Growth Rate % -3.50
y-y EBITDA Growth Rate % --
EV-to-EBIT -0.67
EV-to-EBITDA -0.70
PEG --
Shares Outstanding M 94.36
Net Margin (%) -344.87
Operating Margin % -415.77
Pre-tax Margin (%) -344.82
Quick Ratio 5.28
Current Ratio 5.28
ROA % (ttm) -56.07
ROE % (ttm) -88.25
ROIC % (ttm) -211.54
Dividend Yield % --
Altman Z-Score -4.17
Piotroski F-Score 4.00
Positive ROA N
Positive CFROA N
Higher ROA y-y Y
Cash flow > Earnings Y
Lower Leverage y-y N
Higher Current Ratio y-y Y
Less Shares Outstanding y-y N
Gross Margin Increase y-y N
Higher Asset Turnover y-y Y
To
EMBED
SAVE
To
EMBED
SAVE

Gurus Latest Trades with NAS:ATRA

NAS:ATRA is held by these investors

Guru Portfolio Date Current Shares % of Shares outstanding % of Total Assets Managed Comment
Seth Klarman 2022-06-30
8,123,616
8.61
0.94%
Total 1

NAS:ATRA Insider Transactions

20/Page
Total 0
20/Page
Total 0

News about NAS:ATRA

Total 0
  • 1